These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 15667956

  • 1. Phase II trial of carmustine, cisplatin, and oral etoposide chemotherapy before radiotherapy for grade 3 astrocytoma (anaplastic astrocytoma): results of North Central Cancer Treatment Group trial 98-72-51.
    Rao RD, Krishnan S, Fitch TR, Schomberg PJ, Dinapoli RP, Nordstrom K, Scheithauer B, O'Fallon JR, Maurer MJ, Buckner JC.
    Int J Radiat Oncol Biol Phys; 2005 Feb 01; 61(2):380-6. PubMed ID: 15667956
    [Abstract] [Full Text] [Related]

  • 2. Pre-irradiation chemotherapy for newly diagnosed high grade astrocytoma.
    Mathieu NT, Genet D, Labrousse F, Bouillet P, Denes SL, Martin J, Labourey JL, Venat L, Clavere P, Moreau JJ.
    Anticancer Res; 2004 Feb 01; 24(2C):1249-53. PubMed ID: 15154655
    [Abstract] [Full Text] [Related]

  • 3. A sequential chemo-radiotherapeutic treatment for patients with malignant gliomas: a phase II pilot study.
    Dazzi C, Cariello A, Giannini M, Del Duca M, Giovanis P, Fiorentini G, Leoni M, Rosti G, Turci D, Tienghi A, Vertogen B, Zumaglini F, De Giorgi U, Marangolo M.
    Anticancer Res; 2000 Feb 01; 20(1B):515-8. PubMed ID: 10769716
    [Abstract] [Full Text] [Related]

  • 4. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
    Ettinger DS, Berkey BA, Abrams RA, Fontanesi J, Machtay M, Duncan PJ, Curran WJ, Movsas B, Byhardt RW, Radiation Therapy Oncology Group 9609.
    J Clin Oncol; 2005 Aug 01; 23(22):4991-8. PubMed ID: 15939930
    [Abstract] [Full Text] [Related]

  • 5. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.
    Prados MD, Seiferheld W, Sandler HM, Buckner JC, Phillips T, Schultz C, Urtasun R, Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1147-52. PubMed ID: 15001257
    [Abstract] [Full Text] [Related]

  • 6. Adjuvant dibromodulcitol and BCNU chemotherapy in anaplastic astrocytoma: results of a randomised European Organisation for Research and Treatment of Cancer phase III study (EORTC study 26882).
    Hildebrand J, Gorlia T, Kros JM, Afra D, Frenay M, Omuro A, Stupp R, Lacombe D, Allgeier A, van den Bent MJ, EORTC Brain Tumour Group investigators.
    Eur J Cancer; 2008 Jun 15; 44(9):1210-6. PubMed ID: 18248979
    [Abstract] [Full Text] [Related]

  • 7. [Acute signs and symptoms of toxicity due to the BOPP regimen (BCNU, vincristine, procarbazine, cisplatin) during treatment of high-grade astrocytoma].
    Jeremić B, Grujicić D, Jevremović S, Mijatović Lj.
    Srp Arh Celok Lek; 1991 Jun 15; 119(9-10):256-8. PubMed ID: 1806994
    [Abstract] [Full Text] [Related]

  • 8. Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.
    Buckner JC, Ballman KV, Michalak JC, Burton GV, Cascino TL, Schomberg PJ, Hawkins RB, Scheithauer BW, Sandler HM, Marks RS, O'Fallon JR, North Central Cancer Treatment Group 93-72-52, Southwest Oncology Group 9503 Trials.
    J Clin Oncol; 2006 Aug 20; 24(24):3871-9. PubMed ID: 16921039
    [Abstract] [Full Text] [Related]

  • 9. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K, Kanaya H, Fujiyama Y, Kim P.
    Acta Neurochir (Wien); 2002 Dec 20; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [Abstract] [Full Text] [Related]

  • 10. Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97-12.
    Komaki R, Swann RS, Ettinger DS, Glisson BS, Sandler AB, Movsas B, Suh J, Byhardt RW.
    Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):342-50. PubMed ID: 15890573
    [Abstract] [Full Text] [Related]

  • 11. Phase II evaluation of infusional etoposide and cisplatin in patients with recurrent astrocytoma.
    Buckner JC, Brown LD, Cascino TL, Gerstner JB, Krook JE, Westberg MW, Wiesenfeld M, O'Fallon JR, Scheithauer B.
    J Neurooncol; 1990 Dec 01; 9(3):249-54. PubMed ID: 2086739
    [Abstract] [Full Text] [Related]

  • 12. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
    Mizoe JE, Tsujii H, Hasegawa A, Yanagi T, Takagi R, Kamada T, Tsuji H, Takakura K, Organizing Committee of the Central Nervous System Tumor Working Group.
    Int J Radiat Oncol Biol Phys; 2007 Oct 01; 69(2):390-6. PubMed ID: 17459607
    [Abstract] [Full Text] [Related]

  • 13. Combined treatment modality for anaplastic oligodendroglioma and oligoastrocytoma: a 10-year update of a phase II study.
    Jeremic B, Milicic B, Grujicic D, Samardzic M, Antunovic V, Dagovic A, Aleksandrovic J.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):509-14. PubMed ID: 15145170
    [Abstract] [Full Text] [Related]

  • 14. Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinoma.
    Kakolyris S, Agelidou A, Androulakis N, Tsaroucha E, Kouroussis Ch, Agelidou M, Karvounis N, Veslemes M, Christophylakis Ch, Argyraki A, Geroyianni A, Georgoulias V.
    Lung Cancer; 2006 Jul 01; 53(1):59-65. PubMed ID: 16716447
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02.
    Rosenthal SA, Bae K, Pienta KJ, Sobczak ML, Asbell SO, Rajan R, Kerlin KJ, Michalski JM, Sandler HM, Radiation Therapy Oncology Group Trial 9902.
    Int J Radiat Oncol Biol Phys; 2009 Mar 01; 73(3):672-8. PubMed ID: 18990504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.